ArticleCureus2025
Comparing the Analgesic Efficacy of the Serratus-Intercostal Plane Block With Conventional Pharmacological Treatment in Patients Following Radical Mastectomy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPostoperative pain following radical mastectomy is common and can significantly impair recovery and quality of life. Regional anesthesia through the serratus-intercostal plane block (BRILMA) has been proposed as an effective strategy for pain control.
objectiveThis study aims to compare the analgesic efficacy of BRILMA versus conventional pharmacological treatment in patients undergoing radical mastectomy. MATERIALS AND
methodsA prospective, observational cohort study with two comparative groups was conducted to evaluate the analgesic effectiveness of BRILMA versus conventional treatment following radical mastectomy. Women over 18 years scheduled for radical mastectomy were enrolled and assigned to groups based on the analgesic technique received during standard clinical care: the BRILMA group (ultrasound-guided block with 15 mL of 3% ropivacaine) and the control group (standard regimen with paracetamol, diclofenac, tramadol, dexamethasone, and ondansetron). The primary outcome was pain intensity, assessed using the Visual Analog Scale (VAS) at 4, 8, 12, and 24 hours postoperatively. Hemodynamic parameters were evaluated, and statistical analysis included Mann-Whitney U tests and chi-square tests.
resultsA total of 13 patients were included (six in the BRILMA group, seven in the control group). VAS scores were significantly lower in the BRILMA group at 8, 12, and 24 hours postoperatively (p<0.05). Additionally, lower systolic blood pressure was observed at 12 hours in the BRILMA group. No complications related to the technique were reported.
conclusionsBRILMA is a safe and effective analgesic technique, demonstrating superiority over conventional treatment for controlling postoperative pain following radical mastectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.